Dr. Sandra Carson, MD

NPI: 1760562193
Total Payments
$224,238
2024 Payments
$77,177
Companies
1
Transactions
27

Payment Breakdown by Category

Consulting$222,474 (99.2%)
Travel$1,737 (0.8%)
Food & Beverage$27.36 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $222,474 17 99.2%
Travel and Lodging $1,737 6 0.8%
Food and Beverage $27.36 1 0.0%
Unspecified $0 3 0.0%

Payments by Type

General
$224,238
24 transactions
Ownership
$0
3 transactions

Top Paying Companies

Company Total Records Latest Year
Agile Therapeutics, Inc. $224,238 27 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $77,177 1 Agile Therapeutics, Inc. ($77,177)
2023 $28,469 8 Agile Therapeutics, Inc. ($28,469)
2022 $56,237 12 Agile Therapeutics, Inc. ($56,237)
2021 $62,355 6 Agile Therapeutics, Inc. ($62,355)

All Payment Transactions

27 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
08/28/2024 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Cash or cash equivalent $77,177.42 General
Category: Birth Control Contraceptive Patch
06/09/2023 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Dividend, profit or other return on investment $42.90 General
Category: Birth Control Contraceptive Patch
06/09/2023 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Dividend, profit or other return on investment $31.20 General
Category: Birth Control Contraceptive Patch
06/08/2023 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Dividend, profit or other return on investment $27.30 General
Category: Birth Control Contraceptive Patch
05/25/2023 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Cash or cash equivalent $13,750.00 General
Category: Birth Control Contraceptive Patch
04/25/2023 Agile Therapeutics, Inc. Twirla (Drug) Travel and Lodging Cash or cash equivalent $381.00 General
Category: Birth Control Contraceptive Patch
02/10/2023 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Cash or cash equivalent $13,750.00 General
Category: Birth Control Contraceptive Patch
01/11/2023 Agile Therapeutics, Inc. Twirla (Drug) Travel and Lodging Cash or cash equivalent $487.00 General
Category: Birth Control Contraceptive Patch
2023 Agile Therapeutics, Inc. $0.00 Ownership
12/31/2022 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Cash or cash equivalent $13,750.00 General
Category: Birth Control Contraceptive Patch
11/10/2022 Agile Therapeutics, Inc. Twirla (Drug) Travel and Lodging Cash or cash equivalent $318.06 General
Category: Birth Control Contraceptive Patch
11/10/2022 Agile Therapeutics, Inc. Twirla (Drug) Travel and Lodging Cash or cash equivalent $241.00 General
Category: Birth Control Contraceptive Patch
11/10/2022 Agile Therapeutics, Inc. Twirla (Drug) Travel and Lodging Cash or cash equivalent $180.00 General
Category: Birth Control Contraceptive Patch
11/10/2022 Agile Therapeutics, Inc. Twirla (Drug) Travel and Lodging Cash or cash equivalent $130.00 General
Category: Birth Control Contraceptive Patch
10/04/2022 Agile Therapeutics, Inc. Twirla (Drug) Food and Beverage In-kind items and services $27.36 General
Category: Birth Control Contraceptive Patch
09/30/2022 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Cash or cash equivalent $13,750.00 General
Category: Birth Control Contraceptive Patch
06/30/2022 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Cash or cash equivalent $13,750.00 General
Category: Birth Control Contraceptive Patch
06/09/2022 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Stock, stock option, or any other ownership interest $170.93 General
Category: Birth Control Contraceptive Patch
06/08/2022 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Dividend, profit or other return on investment $169.57 General
Category: Birth Control Contraceptive Patch
03/31/2022 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Cash or cash equivalent $13,750.00 General
Category: Birth Control Contraceptive Patch
2022 Agile Therapeutics, Inc. $0.00 Ownership
10/22/2021 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Cash or cash equivalent $13,750.00 General
Category: Birth Control Contraceptive Patch
07/16/2021 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Cash or cash equivalent $13,750.00 General
Category: Birth Control Contraceptive Patch
06/09/2021 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Dividend, profit or other return on investment $7,354.65 General
Category: Birth Control Contraceptive Patch
04/23/2021 Agile Therapeutics, Inc. Twirla (Drug) Consulting Fee Cash or cash equivalent $13,750.00 General
Category: Birth Control Contraceptive Patch

About Dr. Sandra Carson, MD

Dr. Sandra Carson, MD is a Reproductive Endocrinology healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760562193.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandra Carson, MD has received a total of $224,238 in payments from pharmaceutical and medical device companies, with $77,177 received in 2024. These payments were reported across 27 transactions from 1 company. The most common payment nature is "Consulting Fee" ($222,474).

Practice Information

  • Specialty Reproductive Endocrinology
  • Other Specialties Reproductive Endocrinology
  • Location New Haven, CT
  • Active Since 10/17/2006
  • Last Updated 07/31/2019
  • Taxonomy Code 207VE0102X
  • Entity Type Individual
  • NPI Number 1760562193

Products in Payments

  • Twirla (Drug) $224,238

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Reproductive Endocrinology Doctors in New Haven